SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001140361-24-005655
Filing Date
2024-02-05
Accepted
2024-02-05 16:12:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFM14A ny20017467x2_defm14a.htm DEFM14A 2041458
2 logo_goldmansachs.jpg GRAPHIC 15819
3 logo_karuna.jpg GRAPHIC 58451
4 ny20017467x2_pc01.jpg GRAPHIC 682764
5 ny20017467x2_pc02.jpg GRAPHIC 464913
  Complete submission text file 0001140361-24-005655.txt   3724430
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-38958 | Film No.: 24595853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)